PETRALLA, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 2.527
AS - Asia 2.086
EU - Europa 1.917
AF - Africa 173
Continente sconosciuto - Info sul continente non disponibili 151
SA - Sud America 112
OC - Oceania 21
Totale 6.987
Nazione #
US - Stati Uniti d'America 2.448
IT - Italia 827
SG - Singapore 565
CN - Cina 450
VN - Vietnam 428
HK - Hong Kong 235
DE - Germania 174
GB - Regno Unito 168
SE - Svezia 156
IN - India 101
FR - Francia 96
NL - Olanda 75
BR - Brasile 71
BD - Bangladesh 70
CI - Costa d'Avorio 63
RU - Federazione Russa 58
FI - Finlandia 56
TG - Togo 54
KR - Corea 51
CA - Canada 50
IE - Irlanda 45
JP - Giappone 44
ZA - Sudafrica 31
BG - Bulgaria 28
ES - Italia 27
PT - Portogallo 25
PH - Filippine 24
UA - Ucraina 24
CH - Svizzera 23
HR - Croazia 23
BE - Belgio 21
PL - Polonia 19
AR - Argentina 16
AU - Australia 15
ID - Indonesia 15
JO - Giordania 14
MX - Messico 14
TR - Turchia 14
AT - Austria 12
GR - Grecia 12
CZ - Repubblica Ceca 10
IR - Iran 10
NG - Nigeria 10
TH - Thailandia 10
TW - Taiwan 10
EE - Estonia 8
PK - Pakistan 8
RO - Romania 8
SC - Seychelles 8
NZ - Nuova Zelanda 6
CO - Colombia 5
EC - Ecuador 5
IQ - Iraq 5
MY - Malesia 5
NO - Norvegia 5
PY - Paraguay 5
AZ - Azerbaigian 4
CL - Cile 4
IL - Israele 4
JM - Giamaica 4
UZ - Uzbekistan 4
VE - Venezuela 4
CR - Costa Rica 3
HU - Ungheria 3
LT - Lituania 3
NI - Nicaragua 3
KG - Kirghizistan 2
LB - Libano 2
LI - Liechtenstein 2
MK - Macedonia 2
NP - Nepal 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MZ - Mozambico 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
UY - Uruguay 1
Totale 6.837
Città #
Singapore 410
Ashburn 285
Bologna 285
Hong Kong 220
Chandler 214
San Jose 160
Fairfield 135
Southend 130
Ho Chi Minh City 114
Dallas 104
Hanoi 95
Hefei 89
Santa Clara 77
Woodbridge 70
Council Bluffs 68
Abidjan 63
Wilmington 61
Los Angeles 60
Houston 59
Ann Arbor 58
Cambridge 57
Redmond 55
Beijing 54
Lomé 54
Helsinki 53
New York 49
Seattle 48
Princeton 46
Dublin 45
Seoul 43
Boardman 40
Turin 37
Lauterbourg 30
Milan 30
Tokyo 29
Berlin 24
Sofia 24
Forlì 23
Brussels 20
Chicago 20
Rome 20
Buffalo 16
San Diego 16
Hyderabad 15
Johannesburg 15
Redwood City 15
Shanghai 15
Washington 15
Amman 14
Frankfurt am Main 14
Guangzhou 14
Haiphong 13
London 13
São Paulo 13
Westminster 13
Des Moines 12
Medford 12
Phoenix 12
Bern 11
Da Nang 11
Montreal 11
Munich 11
Redondo Beach 11
Amsterdam 10
Atlanta 10
Biên Hòa 10
Brisbane 10
Nanjing 10
Nuremberg 10
Rimini 10
Warsaw 10
Wayne 10
Abeokuta 9
Boston 9
New Delhi 9
Toronto 9
Bengaluru 8
Brooklyn 8
Can Tho 8
Dearborn 8
Guimarães 8
Jakarta 8
Saint Petersburg 8
The Dalles 8
Utrecht 8
Athens 7
Falkenstein 7
Falls Church 7
Taipei 7
Tianjin 7
Bremen 6
Castenaso 6
Dhaka 6
Hải Dương 6
Jiaxing 6
Jinan 6
Lisbon 6
Madrid 6
Naples 6
Oakland 6
Totale 4.143
Nome #
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential 440
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 414
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency 347
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 345
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo 289
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 289
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches 264
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors 262
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 255
Chronic treatment with hormonal contraceptives alters hippocampal BDNF and histone H3 post-translational modifications but not learning and memory in female rats 252
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease 249
Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia 239
N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study 237
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. 232
Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose 229
α-linolenic acid-valproic acid conjugates: Toward single-molecule polypharmacology for multiple sclerosis 228
Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy 220
Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology. 215
Tampering with microglia-mediated neuroinflammation by means of DNA nanostructures 214
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy 213
Unveiling the role of exosomal miRNAs in the spreading of neuroinflammation 211
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease 201
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 177
Ketone bodies resume mitochondrial respiration in neuronal progenitors from iPSCs of patients with AGC1 deficiency 167
Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. 156
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 148
Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors 114
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease 109
null 98
A nutritional approach to tackle Alzheimer's disease: a key role for immunomodulation 94
null 79
Totale 6.987
Categoria #
all - tutte 18.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022731 0 18 44 38 76 43 40 111 69 74 106 112
2022/2023974 90 157 59 102 63 80 36 68 147 43 76 53
2023/2024407 32 44 31 34 32 87 30 43 15 20 26 13
2024/2025951 62 89 89 78 108 67 83 76 24 69 61 145
2025/20262.630 189 246 220 196 254 148 498 91 384 165 117 122
2026/2027173 79 94 0 0 0 0 0 0 0 0 0 0
Totale 6.987